Assessing the value and affordability of cholesterol reduction in the managed care setting.
Gonzalez
E R
ER
Department of Pharmacy and Pharmaceutics, Virginia Commonwealth University, Medical College of Virginia, Richmond 23298, USA.
Kannewurf
B S
BS
D000924:Anticholesteremic Agents / Q000191:economics / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000191:economics* / Q000401:mortality / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000453:epidemiology; D008078:Cholesterol, LDL / Q000097:blood; D017281:Cost of Illness; D016527:Drug Costs; D004502:Education, Medical, Continuing; D005569:Formularies as Topic; D006801:Humans; D008329:Managed Care Programs / Q000191:economics* / Q000592:standards; D012307:Risk Factors; D014481:United States